AXYS Analytical Services
Sidney
About AXYS Analytical Services
AXYS has come a long way since spring 1974 when we began benchmarking contaminants in Canada’s Arctic ahead of oil and gas development. In the last forty years we’ve evolved into North America’s leading commercial laboratory focused on organic contaminant measurement in all matrices for multiple industries and governments around the world. Our success is largely due to the partnership with our clients and their relentless pursuit of understanding environmental impacts founded on scientific rigour, technical expertise and highest integrity data. You’ve demanded excellence and exhorted us to stretch to meet your needs. Along the way, we’ve innovated and found better ways to support scientifically defensible presentation of key and emerging issues – PCBs in mothers’ milk, naphthenic acids in Oil Sands waters, pharmaceuticals in waste water effluent and more. Analytical leadership requires scientific excellence and specialized expertise. AXYS focuses on the analysis of emerging organic contaminants using advanced gas and liquid chromatographic techniques, linked with single and tandem mass spectroscopy. We precisely characterize and measure the chemical contaminants in samples as varied as human blood, fish tissue, water and sediments. Our ability to detect extremely low concentrations of organic chemicals, in small sample sizes and complex and matrices, is unmatched by conventional, general service, environmental laboratories. Industry leading ultra-trace analysis and multi-matrix combined extraction techniques, paired with exceptional client supporting chemical interpretation, delivers true “analytical advantage” to our clients: The leading lab and most precise data to best inform your decisions.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Website: axysanalytical.com
- Phone: (250)655-5800
Social Profiles
Canonical: https://fsome.com/organization/axys-analytical-services-2080266 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.